PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
18051908-0	2007	[Effects of tetrandrine on Ang II-induced cardiomyocyte hypertrophy and p-ERK1/2 expression].	tetrandrine	12-23	angiotensinogen	Rattus norvegicus	27-33	
18051908-1	2007	OBJECTIVE: To observe effects of tetrandrine (Tet) on angiotensin II (Ang II)-induced cardiomyocyte hypertrophy and the activity and expression of phosphorylated ERK1/2 (p-ERK1/2).	tetrandrine	33-44	angiotensinogen	Rattus norvegicus	54-68	
18051908-1	2007	OBJECTIVE: To observe effects of tetrandrine (Tet) on angiotensin II (Ang II)-induced cardiomyocyte hypertrophy and the activity and expression of phosphorylated ERK1/2 (p-ERK1/2).	tetrandrine	33-44	angiotensinogen	Rattus norvegicus	70-76	
12466049-3	2002	RESULTS: Tetrandrine inhibited calcium agonist BayK8644, endothelin-1 and thromboxane A2 mimetic U46619, angiotensin II- and neuropeptide Y-induced contractile responses with depression of the maximal contraction of pulmonary artery rings in a varying extent.	tetrandrine	9-20	angiotensinogen	Rattus norvegicus	105-119	
12585075-7	2001	Tet (0.1-10 mumol.L-1) treatment in vitro induced a concentration dependent depression [3H]-proline incorperation stimulated by NE or Ang II in AVSMCs from either Sham or RHR.	tetrandrine	0-3	angiotensinogen	Rattus norvegicus	134-140